Literature DB >> 5545899

Effects of immunosympathectomy on development of high blood pressure in genetically hypertensive rats.

D W Clark.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5545899     DOI: 10.1161/01.res.28.3.330

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


× No keyword cloud information.
  7 in total

1.  Effects of 6-hydroxydopamine on spontaneously hypertensive rats.

Authors:  H Vapaatalo; R Hackman; P Anttila; V Vainionpää; P J Neuvonen
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1974       Impact factor: 3.000

2.  Proceedings: The recovery of vascular adrenergic nerve function in the rat after chemical sympathectomy with 6-hydroxydopamine.

Authors:  L Finch; G Haeusler; H Kuhn; H Thoenen
Journal:  Br J Pharmacol       Date:  1972-02       Impact factor: 8.739

3.  Involvement of uptake1 and uptake2 in terminating the cardiovascular activity of noradrenaline in normotensive and genetically hypertensive rats.

Authors:  C Bell; R Kushinsky
Journal:  J Physiol       Date:  1978-10       Impact factor: 5.182

4.  Long-lasting peripheral and central effects of 6-hydroxydopamine in rats.

Authors:  D W Clark; R Laverty; E L Phelan
Journal:  Br J Pharmacol       Date:  1972-02       Impact factor: 8.739

5.  Rapid recovery of vascular adrenergic nerves in the rat after chemical sympathectomy with 6-hydroxydopamine.

Authors:  L Finch; G Haeusler; H Kuhn; H Thoenen
Journal:  Br J Pharmacol       Date:  1973-05       Impact factor: 8.739

6.  Resistance of noradrenaline in blood vessels to depletion by 6-hydroxydopamine or immunosympathectomy.

Authors:  B A Berkowitz; S Spector; J H Tarver
Journal:  Br J Pharmacol       Date:  1972-01       Impact factor: 8.739

7.  Antihypertensive effects of chronic 5-hydroxytryptamine (5-HT2) receptor blockade with ketanserin in the spontaneously hypertensive rat.

Authors:  A Pettersson; B Persson; M Henning; T Hedner
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-08       Impact factor: 3.000

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.